Supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation. Items may contain pharmaceutical promotional information.

FINAL Ipsen supplement image

Exploring decisions surrounding the optimisation of Androgen Deprivation Therapy (ADT) use for appropriate prostate cancer (PCa) patients in the NHS in light of COVID-19

Commissioned by Ipsen UK Ltd

Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Ipsen UK Ltd and developed in partnership with Guidelines in Practice.
View DECAPEPTYL® SR (triptorelin) 3mg, DECAPEPTYL® SR (triptorelin) 11.25mg and DECAPEPTYL® SR (triptorelin) 22.5mg prescribing information and adverse event reporting information here
TRI-UK-004677
Date of preparation: October 2021

Index image digital supplement

Best practice in the management of advanced breast cancer: the role of CDK4/6 inhibitors versus chemotherapy – A Pfizer sponsored roundtable discussion

Commissioned and funded by Pfizer Ltd

This content has been produced in line with the IBRANCE®▼ (palbociclib) Summary of Product Characteristics for Great Britain. This piece is intended for GB healthcare professionals only. This roundtable discussion has been commissioned and funded by Pfizer Ltd and developed in partnership with Guidelines in Practice
Prescribing information and adverse event reporting information for IBRANCE® (palbociclib) for Great Britain can be accessed here
PP-IBR-GBR-3703 | Date of preparation: October 2021

Front cover image

The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document

Commissioned by STADA incorporating Thornton & Ross

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d  Date of preparation: August 2021

Index image

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

Supported by an educational grant from Sanofi Ltd

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd

heart ecg_AS

Improving outcomes in the management of patients with chronic coronary syndrome and stable anginal chest pain for the acute and general physician

Commissioned and funded by A. Menarini Farmaceutica Internazionale SRL

Information intended for UK healthcare professionals only.
This promotional supplement has been commissioned and funded by A. Menarini Farmaceutica Internazionale SRL and developed in partnership with Guidelines in Practice.
View Ranexa (ranolazine) prescribing information and adverse event reporting information here
PP-RA-UK-0627
Date of preparation: July 2021

FINAL index image

Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*

Commissioned by Accord UK Ltd

Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021

20210329 Prostap RTD_final COVER

Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021

Front cover 20201202 Plenvu supplement December 2020 PI

Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK

Commissioned by Norgine Pharmaceuticals Limited

This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.